Skip to contentB
Boston Scientific Corp
B
BSXBoston Scientific Corp Source filing unavailable
Q2 2016 · —
Revenue$2.13B$2.13B+7.4% vs Q2 2015 Net Income-$207.00M-$207.00MN/M vs Q2 2015 EPS Diluted-$0.15-$0.15N/M vs Q2 2015 Gross Profit$1,487,000,000+14.1% Operating Income-$334,000,000N/M Operating Cash Flowderived
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Boston Scientific Corp · CIK 885725 · Engraved from SEC EDGAR
$421,000,000
+601.7%
Free Cash Flowderived$343,000,000+2,350.0% Margins · derivedGross margin69.9%+4.1 pt vs Q2 2015
Operating margin-15.7%−26.8 pt vs Q2 2015
Net margin-9.7%−14.9 pt vs Q2 2015